Philips (PHIA) Given Average Rating of “Buy” by Analysts

Shares of Philips (AMS:PHIA) have been assigned a consensus rating of “Buy” from the sixteen brokerages that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and ten have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is €36.04 ($43.95).

A number of research firms have issued reports on PHIA. JPMorgan Chase set a €36.80 ($44.88) price objective on shares of Philips and gave the stock a “neutral” rating in a report on Wednesday, January 10th. S&P Global set a €36.00 ($43.90) price objective on shares of Philips and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Commerzbank set a €39.00 ($47.56) price objective on shares of Philips and gave the stock a “buy” rating in a research report on Monday, March 19th. Goldman Sachs set a €38.00 ($46.34) price objective on shares of Philips and gave the stock a “buy” rating in a research report on Thursday, April 12th. Finally, UBS set a €38.00 ($46.34) price objective on shares of Philips and gave the stock a “buy” rating in a research report on Friday, March 16th.

AMS:PHIA traded up €0.97 ($1.18) during mid-day trading on Thursday, hitting €32.72 ($39.90). 4,210,000 shares of the company’s stock were exchanged, compared to its average volume of 3,650,000. Philips has a fifty-two week low of €28.92 ($35.27) and a fifty-two week high of €36.12 ($44.05).

About Philips

Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.

Analyst Recommendations for Philips (AMS:PHIA)

Receive News & Ratings for Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philips and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply